Athenahealth morgan stanley performance

Morgan Stanley Ignores Einhorn, Remains Positive On Athenahealth, Inc

Nearly seven days after David Einhorn announced his short attack on Athenahealth, Inc (NASDAQ:ATHN), a Morgan Stanley report doesn't mention the incident in its May 12 research note on the stock.
Athenahealth: Morgan "overweight," notes potential for cost savings in sales, R&D

The report, which has Athenahealth, Inc (NASDAQ:ATHN) as an “overweight” in the portfolio, noted that “Steady state margins reflect the underlying earnings power . . .


This content is exclusively for paying members. Sign up here

If you are subscribed and having an account error please clear cache and cookies if that does not work email or click chat

Saved Articles

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Are you an intelligent investor?

ValueWalkPremium is a website and newsletter for smart investors like yourself. We focus on the latest hedge fund industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today for only a few dollars a day and get a 3 day no obligation trial with a targeted 20% discount coupon code.

Cancel anytime during trial and you are never charged.

Limited time offer: For first 50 subscribers